[Clinical and psychometric observations on the therapeutic effect of an association of GABA-1-glutamine-aspartate-pyridoxal-phosphate in a group of psychoneurotic neurasthenic patients].
D000293:Adolescent; D000328:Adult; D000613:Aminobutyrates / Q000627:therapeutic use*; D001224:Aspartic Acid / Q000627:therapeutic use*; D005973:Glutamine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009440:Neurasthenia / Q000188:drug therapy*; D009497:Neurotic Disorders / Q000188:drug therapy*; D011732:Pyridoxal Phosphate / Q000627:therapeutic use*
D000613:Aminobutyrates; D005973:Glutamine; D001224:Aspartic Acid; D011732:Pyridoxal Phosphate
Osservazioni cliniche e psicometriche sull'effetto terapeutico di un'associazione GABA-1-glutammina-aspartati-piridossalfosfato in un gruppo di psiconevrosici neurastenici.